| 000 | 01659 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515222815.0 | ||
| 264 | 0 | _c20100805 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a0379-0355 | ||
| 024 | 7 |
_a10.1358/mf.2010.32.3.1423888 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVelpandian, T | |
| 245 | 0 | 0 |
_aEvaluation of calcium dobesilate for its anti-cataract potential in experimental animal models. _h[electronic resource] |
| 260 |
_bMethods and findings in experimental and clinical pharmacology _cApr 2010 |
||
| 300 |
_a171-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 |
_aAldehyde Reductase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium Dobesilate _xadministration & dosage |
| 650 | 0 | 4 |
_aCataract _xdrug therapy |
| 650 | 0 | 4 | _aChick Embryo |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGalactose _xtoxicity |
| 650 | 0 | 4 |
_aHemostatics _xadministration & dosage |
| 650 | 0 | 4 |
_aHydrocortisone _xanalogs & derivatives |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOphthalmic Solutions |
| 650 | 0 | 4 | _aOxidative Stress |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSodium Selenite _xtoxicity |
| 700 | 1 | _aNirmal, J | |
| 700 | 1 | _aGupta, P | |
| 700 | 1 | _aVijayakumar, A R | |
| 700 | 1 | _aGhose, S | |
| 773 | 0 |
_tMethods and findings in experimental and clinical pharmacology _gvol. 32 _gno. 3 _gp. 171-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1358/mf.2010.32.3.1423888 _zAvailable from publisher's website |
| 999 |
_c19804495 _d19804495 |
||